41 related articles for article (PubMed ID: 2783572)
1. Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.
Iwahashi T; Tone Y; Usui J; Watanabe H; Sugawara I; Mori S; Okazaki H
Cancer Immunol Immunother; 1989; 30(4):239-46. PubMed ID: 2598192
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
[TBL] [Abstract][Full Text] [Related]
3. The influence of anti-(ricin toxin A chain) monoclonal antibodies on the pharmacokinetics of ricin toxin A chain and recombinant ricin A chain in mice.
Pimm MV; Gunn B; Lord JM; Baldwin RW
Cancer Immunol Immunother; 1990; 32(4):235-40. PubMed ID: 2261597
[TBL] [Abstract][Full Text] [Related]
4. Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomas.
Ding L; Samuel J; MacLean GD; Noujaim AA; Diener E; Longenecker BM
Cancer Immunol Immunother; 1990; 32(2):105-9. PubMed ID: 2289202
[TBL] [Abstract][Full Text] [Related]
5. Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro.
Lüders G; Köhnlein W; Sorg C; Brüggen J
Cancer Immunol Immunother; 1985; 20(1):85-90. PubMed ID: 2933140
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Human Cancer Associated Globo-H (MBr1) Glycosylamino Acid: Some Mechanistic and Conformational Reinvestigations.
Zhu J; Wan Q; Yang G; Ouerfelli O; Danishefsky SJ
Heterocycles; 2009 Apr; 79(1):441-449. PubMed ID: 21423783
[TBL] [Abstract][Full Text] [Related]
7. Microbial ribonucleases (RNases): production and application potential.
Hameş EE; Demir T
World J Microbiol Biotechnol; 2015 Dec; 31(12):1853-62. PubMed ID: 26433394
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
9. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
Rathore D; Batra JK
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
[TBL] [Abstract][Full Text] [Related]
10. Identification and evaluation of a major cytotoxin of A. fumigatus.
Madan T; Arora N; Sarma PU
Mol Cell Biochem; 1997 Feb; 167(1-2):89-97. PubMed ID: 9059985
[TBL] [Abstract][Full Text] [Related]
11. A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.
Casalini P; Caldera M; Canevari S; Ménard S; Mezzanzanica D; Tosi E; Gadina M; Colnaghi MI
Cancer Immunol Immunother; 1993 Jul; 37(1):54-60. PubMed ID: 8099847
[TBL] [Abstract][Full Text] [Related]
12. Transformation of Aspergillus giganteus to hygromycin B resistance.
Wnendt S; Jacobs M; Stahl U
Curr Genet; 1990 Jan; 17(1):21-4. PubMed ID: 2178785
[TBL] [Abstract][Full Text] [Related]
13. Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide.
Lamy B; Davies J
Nucleic Acids Res; 1991 Mar; 19(5):1001-6. PubMed ID: 2020539
[TBL] [Abstract][Full Text] [Related]
14. Systemic immunotoxin therapy of cancer: advances and prospects.
Wawrzynczak EJ
Br J Cancer; 1991 Oct; 64(4):624-30. PubMed ID: 1911210
[No Abstract] [Full Text] [Related]
15. The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells.
Conde FP; Orlandi R; Canevari S; Mezzanzanica D; Ripamonti M; Muñoz SM; Jorge P; Colnaghi MI
Eur J Biochem; 1989 Jan; 178(3):795-802. PubMed ID: 2783572
[TBL] [Abstract][Full Text] [Related]
16. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
[TBL] [Abstract][Full Text] [Related]
17. Activity of recombinant mitogillin and mitogillin immunoconjugates.
Better M; Bernhard SL; Lei SP; Fishwild DM; Carroll SF
J Biol Chem; 1992 Aug; 267(23):16712-8. PubMed ID: 1644844
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
